Solara Active Pharma Sciences Limited
NSE: SOLARA | Information Technology
Market Fundamentals
Stock Intelligence & News
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2,250 Equity Shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2018 |SUBJECT: ESOP/ESOS/ESPS
Read Full Analysis →Solara Active Pharma Sciences Limited
Significant increase in volume has been observed in Solara Active Pharma Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Solara Active Pharma Sciences Limited has submitted their response. |SUBJECT: Spurt in Volume
Read Full Analysis →Solara Active Pharma Sciences Limited
Pronomz Ventures LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Listing of further issue of Solara Active Pharma Sciences Limited
Listing of further issue of Solara Active Pharma Sciences Limited
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of earnings conference call pertaining to financial results of the Company for the quarter and year ended March 31, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding the approval and adoption of Board Evaluation policy and amendment to Whistle Blower Policy. |SUBJECT: General Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |SUBJECT: Statement of deviation(s) or variation(s) under Reg. 32
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 2,200 Equity Shares pursuant to exercise of ESOP Options. |SUBJECT: ESOP/ESOS/ESPS
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the exchange regarding the reappointment of Internal Auditor and Cost Auditor for the FY 2026-27. |SUBJECT: General Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Conversion Of Partly Paid Up Rights Equity Shares into Fully Paid Up Equity Shares in Relation to The Rights Issue by the Company, upon receipt of the Second and Final Call Monies |SUBJECT: Updates
Read Full Analysis →Get instant alerts when SOLARA breaks news
Join investors who track Solara Active Pharma Sciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SOLARA?
SOLARA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Solara Active Pharma Sciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SOLARA to your custom watchlist.